Shree Ram Proteins Q1 FY27: Losses widen as operations remain muted

Shree Ram Proteins Limited informed the National Stock Exchange that its Board met on August 17, 2026 and approved two sets of results: unaudited numbers for the quarter ended June 30, 2026 and audited numbers for the quarter and year ended March 31, 2026.

The June 2026 quarter shows a company still operating with a constrained core business and relying largely on other income. Total income for Q1 FY27 stood at Rs 140.17 lakhs, coming entirely from other income, with revenue from operations reported as nil. Against this, total expenses were Rs 776.33 lakhs, leading to a loss for the quarter of Rs 636.40 lakhs. Earnings per share for the quarter was negative at Rs 0.30.

Taken together with the audited FY26 disclosures, the message is consistent: the company is in a stressed financial position with loan and statutory defaults, a longer working capital cycle, and key operating assets sold by the lender. Management has stated it is exploring funding options, but the auditor has flagged material uncertainty related to going concern and issued an adverse opinion on the FY26 financial results.

Q1 FY27: Income without operations, costs without scale

The June 2026 quarter is striking because it shows no revenue from operations, but a meaningful line in other income. Other income rose to Rs 140.17 lakhs in Q1 FY27, compared with Rs 1.37 lakhs in the corresponding quarter last year. That jump supported the quarter’s total income, but it did not change the underlying picture that the operating business has not resumed at a meaningful level.

On the cost side, the quarter carried heavy expenses relative to income. Other expenses alone were Rs 772.33 lakhs. Depreciation and amortisation was Rs 8.76 lakhs. Employee benefit expense was Rs 4.08 lakhs. Finance costs were reported at Rs 720.08 lakhs for the June 2026 quarter, which is unusually high compared with the audited March 2026 quarter finance cost of Rs 1.06 lakhs, and should be read carefully alongside the audit observations on interest accounting.

The quarter ended with a loss before tax of Rs 636.16 lakhs and a loss after tax of Rs 636.40 lakhs. Total comprehensive income for the quarter was a loss of Rs 637.11 lakhs.

The company also disclosed that it operates in a single segment, solvent products, and therefore does not provide segment reporting under Ind AS 108. This simplifies reporting but also limits visibility into product-level recovery, especially when operations are effectively inactive.

FY26 audited results: Large exceptional items and continuing stress

The audited FY26 results add important context. Total income for FY26 was Rs 2.40 lakhs, far below FY25’s Rs 255.40 lakhs. Total expenses in FY26 were Rs 363.44 lakhs versus Rs 499.39 lakhs in FY25, reflecting a company running at sharply reduced scale.

FY26 posted a loss before exceptional items and tax of Rs 360.61 lakhs. Exceptional items for the year were substantial at Rs 613.92 lakhs. The notes explain that loss in the current reporting period was on account of inventory written off amounting to Rs 61.92 lakhs, compared with Rs 1,857.20 lakhs in the previous year. After considering exceptional items and tax, FY26 net loss stood at Rs 1,010.85 lakhs.

Balance sheet numbers show that the company remains asset-heavy in current assets but burdened by borrowings and other liabilities. As at March 31, 2026, total assets were Rs 6,946.98 lakhs. Inventories were Rs 1,118.36 lakhs. Trade receivables were Rs 2,364.95 lakhs. Cash and cash equivalents were just Rs 1.35 lakhs, underlining liquidity tightness.

On the liabilities side, long-term borrowings were Rs 1,702.98 lakhs and short-term borrowings were Rs 2,011.57 lakhs. Other non-current liabilities were Rs 1,708.27 lakhs. Creditors other than micro and small enterprises were Rs 1,203.63 lakhs.

Equity also weakened. Equity share capital was Rs 2,144.00 lakhs and other equity was negative at Rs 603.70 lakhs, leaving total equity of Rs 1,534.20 lakhs.

Liquidity and funding: OTS setbacks, working capital strain, and asset auction

Several disclosures point to a prolonged liquidity and solvency challenge.

First, the company accepted a one-time settlement of secured loan dues with Union Bank of India. It paid Rs 242.50 lakhs as an upfront instalment but failed to pay the second instalment of Rs 376.25 lakhs and also did not meet the final instalment due on March 31, 2025 of Rs 1,856.25 lakhs, as described in the June 2026 quarter notes. In the audited March 2026 notes, the company also stated it accepted another OTS acknowledgement dated December 4, 2025, paid Rs 470.00 lakhs upfront, and had a balance amount of Rs 3,000.50 lakhs required to be paid within three months from the date of OTS.

Second, management stated it is in the process of raising additional funds and faces a shortage of working capital due to an increase in its working capital cycle. It also stated it is in default of covenants on bank loans and has not paid various statutory dues.

Third, a major operational hit is the reported auction sale by Union Bank of India of the company’s plant and machinery for Rs 382.00 lakhs on May 18, 2026. This is one of the clearest indicators that operational continuity is under pressure and the asset base used to generate solvent product revenues has been impaired.

Cash flow disclosures for FY26 show limited movement in cash balances, ending the year with Rs 1.35 lakhs. Net profit before tax was a loss of Rs 974.53 lakhs. Depreciation of Rs 56.51 lakhs was a non-cash add back. Provision for doubtful debts was Rs 212.64 lakhs. Working capital adjustments show inventories decreased by Rs 705.40 lakhs, trade receivables decreased by Rs 613.92 lakhs, and trade payables and other liabilities increased by Rs 181.52 lakhs. Net cash flow from financial activities was negative at Rs 100.18 lakhs.

These numbers suggest the company’s reported operating cash movement is dominated by working capital changes rather than by profits from operations. When operations are minimal, working capital reversals can temporarily support cash flow, but that does not resolve underlying repayment capacity.

Audit and going concern: What the qualifications mean for investors

The most important analytical signal in this disclosure set is the auditor commentary. For the quarter ended June 30, 2026, the limited review report highlights material uncertainty related to going concern and points to management’s disclosures about shortage of funds, repayment of loans, and payment of statutory dues. The auditor notes that if the company cannot improve its financial situation in the immediate future, it may cease to be a going concern and be in default of financial covenants.

For the audited FY26 financial results, the statutory auditor issued an adverse opinion. The basis includes several points that directly affect how investors should read the reported statements:

One, the auditor draws attention to default in repayment of loans and statutory dues and states that preparing the financial statements on a going concern basis is not in accordance with Ind AS 1.

Two, the auditor states the company has not booked interest for working capital loan and term loan from bank as per Ind AS 109. This matters because interest recognition affects both profit or loss and the reported liability profile. When interest is not accounted for appropriately, losses and borrowings may be understated in reported numbers.

Three, the auditor notes the company has not carried out balance confirmations or reconciliations with debtors, creditors, and advances. It also states that inventories were not inspected in the presence of auditors, and that physical inspection of property, plant, and equipment was not carried out. The auditor further states the company has not performed impairment assessments for key balance sheet items such as property, plant and equipment, inventories, advances, cash and bank balances, and debtors.

In practical terms, these observations introduce uncertainty around the recoverability of receivables, the realizable value of inventories, and the true condition of fixed assets. When combined with the auction of plant and machinery and ongoing defaults, the risk is not only that earnings remain weak, but that balance sheet values could change materially as reconciliations, impairments, and interest recognition catch up.

Closing view: A quarter defined by financial stress, not operating momentum

Shree Ram Proteins’ June 2026 quarter does not read like an operating turnaround. It reads like a holding pattern under stress. Income is driven by other income, not operations. Expenses remain large relative to income. Losses have widened sequentially from the audited March 2026 quarter.

The audited FY26 disclosures make the bigger issue clear. The company has faced repeated setbacks in loan settlements, has very low cash balances, and has seen its plant and machinery auctioned by the bank. Auditors have highlighted going concern uncertainty and issued an adverse opinion, citing issues including loan interest accounting and lack of key reconciliations and inspections.

For investors, the near-term question is not about margin expansion or segment growth. It is about survivability and clarity. The company has stated it is exploring funding options and avenues to mitigate circumstances. Until there is evidence of stable funding, credible compliance with OTS terms, and a return to meaningful revenue from operations, the financial story is likely to remain dominated by balance sheet risk and audit qualifications.

The key takeaway is simple. The quarter underscores a company in restructuring mode, where the credibility of numbers and the path to operating continuity matter as much as the numbers themselves.